Absolutely Brilliant Stocks to Buy According to Rani Jarkas

It can be challenging for investors to make decisions when volatility is high. The best approach is to focus on businesses that should be strong regardless of how the overall market performs. Here are three brilliant stocks to buy in an uncertain market according to Rani Jarkas, a veteran financial advisor with proven and remarkable financial industry experience.

  1. Easterly Government Properties

You won’t find many stocks with a more reliable underlying business than Easterly Government Properties (NYSE: DEA). The real estate investment trust (REIT) specializes in leasing properties to U.S. federal government agencies.

Easterly continues to grow. Last year, the company purchased 12 new properties to lease out. Those additions brought its total number of properties owned to 89. Easterly expects to close on at least another six properties by the end of 2023. The REIT also offers a dividend that currently yields more than 5.1%.

  1. Brookfield Renewable

Some of the market volatility that we’re experiencing is due to soaring oil prices. And those sky-high prices have resulted in a spotlight being focused on the renewable energy industry. Brookfield Renewable (NYSE: BEP) (NYSE: BEPC) stands out as the best renewable energy stock around.

Brookfield Renewable operates hydroelectric, wind, solar, and storage facilities spread across four continents. It boasts over 21,000 megawatts in installed capacity. In addition to its strong growth prospects, Brookfield Renewable also has an attractive dividend yield, which currently tops 3%.

  1. Pfizer

Pfizer (NYSE: PFE) could have more upside potential than meets the eye. The company’s 2022 guidance projects $32 billion in sales for COVID-19 vaccine Comirnaty and $22 billion in sales for COVID-19 pill Paxlovid. Both figures are likely to be higher.

Pfizer also has other growth drivers in its lineup, including blood thinner Eliquis and rare-disease drug Vyndaqel/Vyndamax. It could have even more on the way. Pfizer picked up the drug with its recent acquisition of Arena Pharmeceuticals.

Rani Tarek Jarkas, a founder of Cedrus Investments equipped with high standards and quality business systems, recommends only approved and high-quality services and products that are fully secure and backed.